Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 2674 of 3330
Next
>>
>
66826 to 66850 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
MB 157	Unknown	Unknown	Sirolimus	MTOR	MTOR	0.000427	uM	9039.068	0.8881	0.5374	0.4510
MB 157	Unknown	Unknown	Sirolimus	MTOR	MTOR	0.00213	uM	9039.068	1.0655	1.3019	0.4510
MB 157	Unknown	Unknown	Sirolimus	MTOR	MTOR	0.0107	uM	9039.068	0.8857	0.5279	0.4510
MB 157	Unknown	Unknown	Sirolimus	MTOR	MTOR	0.0533	uM	9039.068	0.8398	0.3581	0.4510
MB 157	Unknown	Unknown	Sirolimus	MTOR	MTOR	0.267	uM	9039.068	0.8474	0.3854	0.4510
MB 157	Unknown	Unknown	Sirolimus	MTOR	MTOR	1.33	uM	9039.068	0.7947	0.2014	0.4510
MB 157	Unknown	Unknown	Sirolimus	MTOR	MTOR	6.67	uM	9039.068	0.8965	0.5695	0.4510
MB 157	Unknown	Unknown	Sirolimus	MTOR	MTOR	33.3	uM	9039.068	0.7949	0.2023	0.4510
MB 157	Unknown	Unknown	Sirolimus	MTOR	MTOR	167	uM	9039.068	0.7552	0.0730	0.4510
MCF 10A	NM	Basal B	Sirolimus	MTOR	MTOR	0.0000853	uM	7483.069	0.9880	0.9923	3.1344
MCF 10A	NM	Basal B	Sirolimus	MTOR	MTOR	0.000427	uM	7483.069	1.0292	1.0185	3.1344
MCF 10A	NM	Basal B	Sirolimus	MTOR	MTOR	0.00213	uM	7483.069	0.9650	0.9774	3.1344
MCF 10A	NM	Basal B	Sirolimus	MTOR	MTOR	0.0107	uM	7483.069	0.8545	0.9022	3.1344
MCF 10A	NM	Basal B	Sirolimus	MTOR	MTOR	0.0533	uM	7483.069	0.7285	0.8077	3.1344
MCF 10A	NM	Basal B	Sirolimus	MTOR	MTOR	0.267	uM	7483.069	0.6707	0.7607	3.1344
MCF 10A	NM	Basal B	Sirolimus	MTOR	MTOR	1.33	uM	7483.069	0.6580	0.7500	3.1344
MCF 10A	NM	Basal B	Sirolimus	MTOR	MTOR	6.67	uM	7483.069	0.6151	0.7128	3.1344
MCF 10A	NM	Basal B	Sirolimus	MTOR	MTOR	33.3	uM	7483.069	0.5644	0.6664	3.1344
MCF 10A	NM	Basal B	Sirolimus	MTOR	MTOR	0.000427	uM	7484.068	0.8553	0.8861	2.6661
MCF 10A	NM	Basal B	Sirolimus	MTOR	MTOR	0.00213	uM	7484.068	0.8416	0.8748	2.6661
MCF 10A	NM	Basal B	Sirolimus	MTOR	MTOR	0.0107	uM	7484.068	0.7051	0.7544	2.6661
MCF 10A	NM	Basal B	Sirolimus	MTOR	MTOR	0.0533	uM	7484.068	0.6363	0.6880	2.6661
MCF 10A	NM	Basal B	Sirolimus	MTOR	MTOR	0.267	uM	7484.068	0.6456	0.6973	2.6661
MCF 10A	NM	Basal B	Sirolimus	MTOR	MTOR	1.33	uM	7484.068	0.5937	0.6447	2.6661
MCF 10A	NM	Basal B	Sirolimus	MTOR	MTOR	6.67	uM	7484.068	0.6361	0.6879	2.6661

|<
<<
Previous
Page 2674 of 3330
Next
>>
>
66826 to 66850 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)